KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Shares Outstanding (Diluted Average) (2020 - 2025)

Historic Shares Outstanding (Diluted Average) for Twist Bioscience (TWST) over the last 6 years, with Q4 2025 value amounting to $61.1 million.

  • Twist Bioscience's Shares Outstanding (Diluted Average) rose 324.19% to $61.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $61.1 million, marking a year-over-year increase of 324.19%. This contributed to the annual value of $59.8 million for FY2025, which is 308.88% up from last year.
  • Twist Bioscience's Shares Outstanding (Diluted Average) amounted to $61.1 million in Q4 2025, which was up 324.19% from $59.8 million recorded in Q3 2025.
  • Twist Bioscience's 5-year Shares Outstanding (Diluted Average) high stood at $61.2 million for Q2 2025, and its period low was $48.3 million during Q3 2021.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $55.9 million, with a median of $57.0 million in 2023.
  • Per our database at Business Quant, Twist Bioscience's Shares Outstanding (Diluted Average) surged by 2312.07% in 2021 and then surged by 133.96% in 2023.
  • Twist Bioscience's Shares Outstanding (Diluted Average) (Quarter) stood at $49.9 million in 2021, then increased by 13.09% to $56.4 million in 2022, then rose by 1.87% to $57.5 million in 2023, then increased by 2.9% to $59.2 million in 2024, then rose by 3.24% to $61.1 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $61.1 million in Q4 2025, compared to $59.8 million in Q3 2025 and $61.2 million in Q2 2025.